We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

BioForce Announces Placement of a NanoArrayer™ System

BioForce Announces Placement of a NanoArrayer™ System

BioForce Announces Placement of a NanoArrayer™ System

BioForce Announces Placement of a NanoArrayer™ System

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BioForce Announces Placement of a NanoArrayer™ System"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioForce Nanosciences has announced placement of a NanoArrayer™ System at North Carolina State University in the laboratory of Dr. Dan Feldheim, Professor of Chemistry.

"The NanoArrayer System provides a unique solution to the problem Dr. Feldheim faces of ultramicro-scale deposition of femtoliter volumes on specialized surfaces developed in his laboratory," noted Dr. Eric Henderson, Founder and CEO at BioForce Nanosciences.

He adds, "In addition to providing this technology, we will also be working with this research group at a collaborative level as they further develop their powerful and novel molecular screening process."

Dr. Feldheim is working with a team of researchers to discover RNA sequences that catalyze the formation of nanomaterials. The team, which includes Professor Bruce Eaton at The University of Colorado, recently found that certain RNA sequences catalyze the formation of new forms of metallic nanoparticles, compositions that may be useful in alternative energy and medical imaging technologies.

Bruce is also excited about implementing this system noting "the Bioforce NanoArrayer System will increase the pace of discovery of catalytically active RNA sequences tremendously."

"This technology has significant market potential in several areas including Molecular Diagnostics, Molecular Detection and Pharma Discovery," observed Dr. Curtis Mosher, Vice President of Research and Development.